• Welcome  
      • Home
    • For Exhibitors  
      • Exhibitor Login
      • Exhibitor Prospectus
      • Exhibitor Service Manual
      • Booth Application
      • Rules and Regulations
    • Floor Plan  
      • Floor Plan
    • Exhibitor List  
      • Exhibitor List
      • Product Gallery
      • Press Releases
      • Show Specials
      • Video Gallery
    • Sponsorship Opportunites
    • Forms/Documents  
      • Credit Card Authorization Form
      • Function Space Request Form
      • Giveaway Request Form
    • Attendee Briefcase  
      • My Profile
    • Search
    • Welcome  
      • Home
    • For Exhibitors  
      • Exhibitor Login
      • Exhibitor Prospectus
      • Exhibitor Service Manual
      • Booth Application
      • Rules and Regulations
    • Floor Plan  
      • Floor Plan
    • Exhibitor List  
      • Exhibitor List
      • Product Gallery
      • Press Releases
      • Show Specials
      • Video Gallery
    • Sponsorship Opportunites
    • Forms/Documents  
      • Credit Card Authorization Form
      • Function Space Request Form
      • Giveaway Request Form
    • Attendee Briefcase  
      • My Profile
    • Search
    1. Exhibitor List

    • Radiopharmaceutical Imaging and Dosimetry (Rapid®) receives FDA clearance for its first 3D-RD™ product: 3D-RD-S First SaaS designed for precise dosing of Radiopharmaceuticals
      Submitted on: Mar 24, 2023, by Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) (#7096)

      Baltimore, Maryland – Rapid is pleased to announce that it has received FDA 510(k) market clearance for its first software product: 3D-RD-S, the first web-browser based application that implements the MIRD Schema to perform radiopharmaceutical dosimetry calculations. It is based on the most recent ICRP phantoms and data, supports 1,252... Learn More

    • Veritas Medical Solutions and NorthStar Medical Radioisotopes Partnered to Construct a Radiation Shielded Vault
      Submitted on: Mar 22, 2023, by Veritas Medical Solutions (#1034)

      Shielding NorthStar's first pair of IBA Rhodotron® accelerators - a first-of-its-kind radioisotope facility. June 27, 2022 11:00 ET | Source: Veritas Medical Solutions... HARLEYSVILLE, Pa., June 27, 2022 (GLOBE NEWSWIRE) -- As part of its expansion of radiation shielding solutions in the Industrial segment for radiopharmaceutical... Learn More

    • Ameriflight Signs Intent to Purchase Agreement with Sabrewing Aircraft for 35 VTOL Air Cargo Drones
      Submitted on: Mar 21, 2023, by Ameriflight LLC (#1051)

      February 14th, 2023 FOR IMMEDIATE RELEASE Media Contact: Jamie Smith Ameriflight, LLC Director of Corporate Communications jsmith@ameriflight.com | 972.426.3066 ext. 76273

      Learn More

    • Ameriflight Signs Agreement with Natilus to Purchase 20 Autonomous Cargo Aircraft
      Submitted on: Mar 21, 2023, by Ameriflight LLC (#1051)

      January 26th, 2023 FOR IMMEDIATE RELEASE Media Contact: Jamie Smith Ameriflight, LLC Director of Corporate Communications jsmith@ameriflight.com | 972.426.3066 ext. 76273

      Learn More

    • Ameriflight Expands Fleet with Fifteen Saab 340B Aircraft from Jetstream
      Submitted on: Mar 21, 2023, by Ameriflight LLC (#1051)

      Saab 340B with digital rendering of Ameriflight livery

      Learn More

    • ZTI BIOSCIENCES, U-CONNECT 2021 FINAL WINNER
      Submitted on: Mar 21, 2023, by ZTI Biosciences (#SB3)

      https://www.youtube.com/watch?v=yUtfcOwfo1U ZTI BIOSCIENCES, Next Generation Radiopharmaceuticals Developer, wins the final award for U-CONNECT 2021 ... Learn More

    • [MBN] ZTI BIOSCIENCES Targeted Radiopharmaceuticals: Next generation cancer therapy
      Submitted on: Mar 21, 2023, by ZTI Biosciences (#SB3)

      https://www.youtube.com/watch?v=Sni8cyKkPo4 [MBN] ZTI BIOSCIENCES Targeted Radiopharmaceuticals: Next generation cancer therapy ZTI BIOSCIENCES was introduced at a national Korean economics broadcaster.  ... Learn More

    • [YTN] Exclusive interview with ZTI BIOSCIENCES, the national leader in radiopharmaceuticals.
      Submitted on: Mar 21, 2023, by ZTI Biosciences (#SB3)

      https://www.youtube.com/watch?v=f_5k8QiHGWo YTN, an official major broadcaster in Korea had an exclusive interview with ZTI BIOSCIENCES, the national leader in radiopharmaceuticals. Dr. Jaden H. Chang, CEO of ZTI BIOSCIENCES explains the nature of Radio Ligand Therapy. CTO Dr. Eugene Park explains ZTI's basic tech.  ... Learn More

    • Plus Therapeutics Announces First Patient Dosed in ReSPECT-GBM Phase 2b Trial of Rhenium (186Re) Obisbemeda for Treatment of Recurrent Glioblastoma
      Submitted on: Mar 15, 2023, by Plus Therapeutics (#8045)

      Plus Therapeutics Announces First Patient Dosed in ReSPECT-GBM Phase 2b Trial of Rhenium (186Re) Obisbemeda for Treatment of Recurrent Glioblastoma... Learn More

    • Plus Therapeutics Completes Enrollment in Second ReSPECT-LM Phase 1 Trial Cohort of Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases
      Submitted on: Mar 15, 2023, by Plus Therapeutics (#8045)

      Plus Therapeutics Completes Enrollment in Second ReSPECT-LM Phase 1 Trial Cohort of Rhenium (¹⁸⁶Re) Obisbemeda for the Treatment of Leptomeningeal Metastases... Learn More

    • GenesisCare, Radiopharm Theranostics Partner to Bring World-First Novel Radiopharmaceuticals to Australian Cancer Patients
      Submitted on: Mar 03, 2023, by GenesisCare Pty Ltd (#7094)

      GenesisCare, Radiopharm Theranostics Partner to Bring World-First Novel Radiopharmaceuticals to Australian Cancer Patients

      Learn More

    Location

    • 1230 East Boston Central Drive      Dallas, TX 75251
    • Phone: +1-555-634-8002
    • Fax: +1-5555-634-8119
    • Web: http://www.entersite.com/

    Quick Links

    • Register as attendee
    • Become and exhibitor
    • View conference sessions
    • View exhibit hall

    Follow Us

    Copyright 2018, a2z, Inc. All rights reserved.